Status:
COMPLETED
PROM Collected Via a WebApp Versus a Touch Screen Solution Among Patients With SLE
Lead Sponsor:
Salome Kristensen
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
18-110 years
Phase:
NA
Brief Summary
A randomised, within-participants cross-over design trial including 34 patients with systemic lupus erythematosus. The participants will be randomised to data registration of patient reported outcome ...
Detailed Description
The aim of this trial is to evaluate whether electronic reporting of PROMs through the DANBIO web application (webapp) is comparable to the outpatient touchscreen among patients with SLE. The trial i...
Eligibility Criteria
Inclusion
- Diagnosed in DANBIO with SLE
- Experience with the PROM questionnaires in DANBIO (≥ 1 previous assessments)
Exclusion
- Inability to provide informed consent or to comply with the study protocol
- Diagnosis of SLE of ≥ 12 months
- Does not have access to a device that can run the DANBIO webapp
Key Trial Info
Start Date :
July 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2020
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04411407
Start Date
July 15 2020
End Date
November 25 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Rheumatology
Aalborg, Denmark, 9000